Overview

Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Phase III study comparing monthly octreotide i.m. in comparison to no additional treatment in patients with proliferative diabetic retinopathy after lasercoagulation.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Octreotide